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Liu T, Li H, Gounko NV, Zhou Z, Xu A, Hong W, Han W. Detection
of insulin granule exocytosis by an electrophysiology method with high
temporal resolution reveals enlarged insulin granule pool in BIG3-knockout
mice. Am J Physiol Endocrinol Metab 307: E611–E618, 2014. First pub-
lished August 19, 2014; doi:10.1152/ajpendo.00208.2014.—We recently
identified BIG3 as a negative regulator of insulin granule biogenesis
and reported increased insulin secretion in BIG3-knockout (BKO)
mice. To pinpoint the site of action for BIG3, we investigated whether
BIG3 regulates quantal insulin granule exocytosis. We established an
assay to detect insulin granule exocytosis by recording ATP-elicited
currents at high temporal resolution by patch clamp. Similarly to
insulin, ATP release was increased in BKO -cells. Although the
frequency of insulin granule exocytosis was increased in BKO -cells,
quantal size or release kinetics remained unchanged. Electron micros-
copy studies showed that the number of insulin granules was in-
creased by 60% in BKO -cells. However, the number of morpho-
logically docked granules was unaltered. The number of insulin
granules having significant distances away from plasma membrane
was greatly increased in BKO -cells. Thus, BIG3 negatively regu-
lates insulin granule exocytosis by restricting insulin granule biogen-
esis without the release kinetics of individual granules at the final
exocytotic steps being affected. Depletion of BIG3 leads to an
enlarged releasable pool of insulin granules, which accounts for
increased release frequency and consequently increased insulin secre-
tion.
brefeldin A-inhibited guanine nucleotide exchange protein 3; Ca2;
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PANCREATIC -CELLS ARE THE MAIN SOURCE of insulin production
and secretion in animals and humans. Insulin is stored in large
dense-core secretory granules in -cells and released via gran-
ule exocytosis upon stimulation. Impaired insulin secretion
from -cells is a main feature of type 2 diabetes (2, 38).
Reduced insulin secretion may be attributed to a number of
factors, including downregulation and impairment of fusion
machinery (29, 34), and changes in granule structure (4, 30,
48). Although the insulin secretion process is relatively well
characterized (2, 38), the mechanisms underlying insulin gran-
ule biogenesis and maturation and their contribution to insulin
release from -cells remain poorly understood.
Insulin granules are originated from the trans-Golgi net-
work, and both their formation and subsequent maturation
require functional Arf GTPases and brefeldin A-sensitive Arf-
GEFs (8, 9). We reported recently that brefeldin A-inhibited
guanine nucleotide exchange protein 3 (BIG3), a large Sec7
domain-containing protein, is a novel negative regulator of
insulin granule biogenesis in -cells (24). BIG3-knockout
(BKO) mice exhibit postprandial hyperinsulinemia, hypergly-
cemia, impaired glucose tolerance, and insulin resistance. In-
terestingly, glucose-stimulated insulin secretion from BKO
islets was increased significantly (24). Although we demon-
strated that increased insulin granule biogenesis and accumu-
lation led to the enhanced insulin secretion, it was not clear
whether insulin granule exocytotic steps were altered. The aim
of the current study was to examine the involvement of BIG3
in the regulation of insulin granule exocytosis at the single
granule level by using patch clamp recordings to understand
how increased granule biogenesis may lead to increased insulin
granule exocytosis and insulin secretion.
ATP is costored and coreleased with insulin in -cells (6, 19,
21, 23). To study exocytosis of individual insulin granules, we
introduced P2X2 cation channel into -cells by adenoviral
transduction and monitored ATP release during granule exo-
cytosis by measuring ATP-induced P2X2 currents (19, 21).
Compared with whole cell membrane capacitance measure-
ments (32) for insulin granule exocytosis and ELISA for
insulin secretion (14), the current ATP-P2X2 assay offers
much higher temporal resolution that is sufficient to resolve a
single granule fusion event. Here, we performed detailed anal-
yses of exocytosis events of insulin granules from BKO and
control mouse islets.
MATERIALS AND METHODS
Animal welfare. All experiments involving animals were reviewed
and approved by the Institutional Animal Care and Use Committee of
A*STAR (Agency for Science, Technology, and Research). All mice
used in this study were bred and housed in our animal facility.
DNA plasmids and virus production. AdP2X2-GFP (green fluores-
cent protein) was created with the AdEasy Adenoviral Vector System
(Agilent Technologies) (28). P2X2-GFP in pEGFP-N1 vector was a
generous gift from Dr. Ruth D. Murrell-Lagnado (University of
Cambridge, Cambridge, UK) (3). To generate pShuttle-CMV-P2X2-
GFP, the coding region of P2X2-GFP was amplified by PCR and
inserted into the KpnI and XhoI sites of pShuttle-CMV vector (Agilent
Technologies). After in vivo homologous recombination in bacteria,
the adenoviral DNA (AdP2X2-GFP) was linearized and transfected
into human embryonic kidney-293T cells to produce adenovirus.
Pancreatic -cells isolation and culture. -Cells from BKO and
control mice were isolated and cultured as described previously (15,
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24). For electrophysiology experiments, -cells were infected with
AdP2X2-GFP 16 h after plating and recorded 24 h later.
Insulin measurements. Isolated pancreatic islets were infected with
AdP2X2-GFP the next morning after isolation and used for experi-
ments 24 h later. Measurement of glucose-induced insulin secretion
from isolated islets was done as described previously (24). Briefly,
batches of eight similar-sized islets were placed in a 100-l flow
chamber under continuous perifusion (0.25 ml/min) with Krebs-
Ringer-HEPES medium (KRH) (in mM: 130 NaCl, 4.7 KCl, 1.2
KH2PO4, 1.2 MgSO4, and 2.56 CaCl2, supplemented with 1 mg/ml
BSA and buffered with 20 mM HEPES-NaOH to pH 7.4) containing
2.8 mM glucose for 30 min at 37°C. The medium was then switched
to KRH containing 16.7 mM glucose for 30 min. Fractions of the
medium were collected every 3 min, starting at 3 min before stimu-
lation. Insulin concentration in each fraction was measured using
Mouse Insulin ELISA (Mercodia).
Electrophysiology. Whole cell patch clamp recording was done as
described previously (16, 25). Cells were bathed in standard extracel-
lular solution containing (in mM) 138 NaCl, 5.6 KCl, 2.6 CaCl2, 1.2
MgCl2, 5 HEPES, and 5 glucose, pH adjusted to 7.4 by NaOH.
Forskolin (10 M; Tocris Bioscience) was included in extracellular
solution in all experiments to enhance -cell exocytosis (1). The bath
was perfused continuously, and all experiments were carried out at
29–30°C (Warner Instruments). -Cells were identified based on their
size (membrane capacitance 5 pF) and the discernible voltage-gated
Na-currents (18). Voltage clamp in the whole cell configuration was
used to record ATP current. Intracellular solution contained (in mM)
125 CsCl, 10 NaCl, 1 MgCl2, 10 EGTA, 9 CaCl2, 3 MgATP, 0.1
cAMP, and 5 HEPES, pH adjusted to 7.15 using CsOH (19). Pipette
resistance was 3–4 M. Membrane potential was clamped at 70
mV. Current was sampled by Pulse software and an EPC-10/2
amplifier (HEKA Elektronik) at 10 kHz with a 2.9-kHz low-pass
filter. A micromanipulator (Sutter Instruments) was used for patch
clamp. For applying ATP onto -cells, a local perfusion system
(Warner Instruments) was used for rapid exchange of extracellular
solution.
FM1-43 staining. FM1-43 staining was done as described previ-
ously (26). Briefly, -cells were treated with FM1-43FX (10 M;
Invitrogen) for 10 min at 37°C in normal extracellular, high-K (KCl,
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Fig. 1. Detection of ATP release and insulin
granule exocytosis by ATP-P2X2 assay in
-cells. A: representative image showing co-
location of ATP and insulin staining in
-cells (n  10). Scale bar, 2 m. B: sche-
matic diagram showing the basic principle of
ATP-P2X2 assay in the detection of ATP
release from -cells. -Cells were infected to
express P2X2-GFP (green fluorescent pro-
tein); 2 M free Ca2 was included in the
patch pipette to trigger exocytosis. C: robust
inward currents induced by ATP in AdP2X2-
GFP-infected cells (n  7) but not in nonin-
fected -cells (n  6). D: intracellular dial-
ysis of 2 M Ca2 triggered robost inward
currents in AdP2X2-GFP-infected cells (n 
10) but not in uninfected -cells (n  12).
Inset: expanded view of the current spike (*).
E: perifusion analysis of glucose-stimulated
insulin secretion (GSIS) in isolated islets
from control (n  10) and virus-infected
islets (n  11) from 3 independent islet
isolations. P  0.05; Student’s t-test. Data
are shown as means 	 SE.
70 mM), or high-glucose (22 mM) solution. After washout, cells were
fixed and then imaged with an A1R confocal microscope (Nikon).
Immunocytochemistry. Before immunostaining, -cells were first
treated with fluorescent dye quinacrine (2 M; Santa Cruz Biotech-
nology) at 37°C for 15 min to label ATP-containing granules (35, 49).
After washout of quinacrine, immunostaining of insulin was done as
reported previously (26). Briefly, -cells were fixed in 4% parafor-
maldehyde and permeabilized with 0.3% Triton X-100. After 2%
BSA blocking, cells were incubated with insulin antibody (Dako)
overnight at 4°C, followed by Alexa Fluor 568-conjugated secondary
antibodies (Invitrogen) at room temperature. Images were taken using
an A1R confocal microscope (Nikon).
Electron microscopy. Electron microscopy was done as described
previously (24). Briefly, islets were dehydrated in an ethanol series
and embedded in araldite epoxy resin. Ultrathin (90 nm) sections were
stained with 2% uranyl acetate (Analar) and examined by using a
JEOL JEM-1220 electron microscope (JEOL Asia Pte). Randomly
selected -cells were imaged. Granules directly touching plasma
membrane without cytoplasma gap were defined as docked granules
(5, 33). All granules in -cells were examined, and cytoplasm area,
granule number, and distance from plasma membrane were measured
in ImageJ [National Institutes of Health (NIH)].
Chemicals and reagents. All chemicals and reagents were pur-
chased from Sigma-Aldrich unless specified otherwise.
Data analysis and statistics. Data were presented as means 	 SE.
All electrophysiological data were analyzed with the Mini Analysis
Program (Synaptosoft) and IGOR software (Wavemetrics). Imaging
data were analyzed with ImageJ (NIH) and Adobe Illustrator (Adobe
Systems). For the analysis of cumulative frequency, significance of
difference was determined with the Kolmogorov-Smirnov test. For all
other analyses, significance of difference was determined by using
Student’s t-test.
RESULTS
Costorage of ATP in insulin-containing granules. Previous
studies have shown that secretory granule exocytosis could be
monitored at high temporal resolution by detecting ATP-
induced P2X2 channel currents and that the approach was
suitable for the analysis of quantal vesicle exocytosis (19, 21).
ATP-containing secretory granules in -cells were stained with
the fluorescent dye quinacrine (35, 49), and insulin was de-
tected with immunostaining. ATP was colocalized with insulin
(Fig. 1A), consistent with previous reports (6, 23). We trans-
duced -cells to express the P2X2 cation channel by using
adenovirus AdP2X2-GFP (Fig. 1B). The GFP signal allowed
easy identification of P2X2-expressing cells. Extracellular ap-
plication of ATP and intracellular dialysis of Ca2 (2 M)
induced robust inward currents in GFP-positive -cells (3, 21),
whereas no current was detected in uninfected control -cells
(Fig. 1, C and D). Because activation of P2X channels modu-
lates vesicle exocytosis in sensory neurons (13, 31), we exam-
ined whether expression of P2X2 channel in -cells affected
insulin secretion. We performed perifusion secretion experi-
ments to measure glucose-stimulated insulin secretion (GSIS)
from isolated pancreatic islets. Unlike in sensor neurons, ex-
pression of P2X2 in -cells had no effect on insulin secretion
(Fig. 1E). These results show that we have established the
ATP-P2X2 assay in -cells for detection of ATP-elicited
inward currents with high temporal resolution by patch clamp
recording.
Increased ATP release from BKO -cells. Our previous
study showed that insulin granule exocytosis and insulin se-
cretion were increased in BKO mouse -cells (24). We first
examined the effect of BIG3 depletion on insulin granule
exocytosis in -cells using the ATP-P2X2 assay. We applied 2
M Ca2 through the patch pipette to trigger Ca2-dependent
exocytosis in -cells under whole cell configuration and re-
corded robust inward currents in P2X2-GFP expressing
-cells, which resemble synaptic currents (Fig. 2A). Total ATP
release was assessed by measuring the charge transfer of
ATP-induced inward currents (Fig. 2A). BKO -cells released
significantly more ATP than control cells (Fig. 2B), consistent
with our previous findings (24).
Increased frequency of secretory granule exocytosis in BKO
-cells. Enhanced granule exocytosis may arise from increased
quantal size, release frequency, or both (46). We analyzed the
ATP-induced currents from BKO and control -cells (Fig. 3A).
The peak amplitude and quantal size of ATP signals were not
affected in BKO -cells (Fig. 3, B and C). On average, the peak
amplitude was 320	 17 pA (n 17 cells) in BKO -cells and
306 	 20 pA (n  19 cells) in control -cells (P  0.05), and
the quantal size was 95 	 18 nC in BKO cells and 97 	 29 nC
in control cells (P  0.05). Other parameters of quantal
current, including 10–90% rise time (24 	 4 s in BKO cells
and 20 	 3 s in control cells, P  0.05), decay time (244 	 38
s in BKO cells and 203 	 32 s in control cells, P  0.05), and
half-width (257	 39 s in BKO cells and 215	 32 s in control
cells, P  0.05), were not affected in BKO cells (Fig. 3C). We
-15
-12
-9
-6
-3
C
ha
rg
e
tra
ns
fe
r(
nC
)
1601208040
Time (s)
Ctrl
BKO
Ctrl BKO
I A
TP
C
ha
rg
e
tra
ns
fe
r
A
B
* * * * * * * *
20 s
40
0 
pA
2 
nC
0
0
Fig. 2. Increased ATP release in brefeldin A-inhibited guanine nucleotide
exchange protein 3 (BIG3)-knockout (BKO) -cells. A: representative traces of
ATP currents in BKO and control -cells. Top traces represent the original
recording and bottom traces integrated charge of the upper currents. B: average
charge transfer in BKO and control -cells at indicated time points [control
(Ctrl), n  19; BKO, n  14]. *P 
 0.05; Student’s t-test. Data are shown as
means 	 SE.
also determined granule exocytosis frequency in BKO and
control cells (Fig. 3D). The quantal release frequency was
more than doubled in BKO cells (0.33 	 0.05 Hz) when
compared with control cells (0.15	 0.03 Hz, P
 0.01). These
results show that enhanced granule exocytosis is due to in-
creased release frequency of secretory granules.
Increased number of recycling granules in BKO -cells. To
ascertain the higher release frequency in BKO cells, we exam-
ined vesicle recycling events by FM1-43 dye staining in BKO
and control -cells (22, 26). Under basal external solution,
there was no difference in the number of puncta between BKO
(5.9 	 1.1; n  8 cells) and control cells (3.8 	 1.0; n  8
cells, P 0.05) (Fig. 4, A and B). However, under high-K (70
mM) or high-glucose (22 mM) stimulation conditions, BKO
-cells displayed a significantly increased number of FM1-43
puncta compared with control-cells (Fig. 4B). There were 15	 1.7
spots (n  8 cells) in BKO cells and 7.5 	 1.3 spots (n  12
cells) in control cells under high-K stimulation (P 
 0.01)
and 25.6 	 3.6 spots (n  9 cells) in BKO cells and 9.9 	 1.2
spots (n  9 cells) in control cells under high-glucose stimu-
lation (P 
 0.01). These results provide further support that
BKO -cells exhibit increased frequency of granule exocyto-
sis.
Enlarged releasable pool of newly formed secretory gran-
ules in BKO -cells. Previously, we showed that BIG3 nega-
tively regulates insulin granule biogenesis and that depletion of
BIG3 results in significantly more insulin granules in -cells
(24). Considering that increased insulin granule exocytosis
persisted during prolonged stimulation (Fig. 2B), which in-
volves secretory granules beyond the docked granules, e.g., the
releasable pool of secretory granules (39), we examined insulin
granule distribution by electron microscopy (19). Consistent
with our previous report, we found that depletion of BIG3
greatly increased the total number of insulin granules (Fig. 5,
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Fig. 3. Increased frequency of granule exocytosis in
BKO -cells. A: representative traces of ATP currents in
BKO and control -cells. Five consecutive recordings
(30 s each) from a single BKO or control -cell were
overlapped. B: statistical analysis of peak amplitude of
ATP currents (Ctrl, n  19 cells; BKO, n  17 cells).
Comparison in cumulative frequency of peak amplitude
was assessed with Kolmogorov-Smirnov test (P 
0.92). C: quantal analysis of ATP currents. D: statistics
of ATP release frequency. **P 
 0.01; Student’s t-test.
Data are shown as means 	 SE.
A and B). On average, the granule density was 2.7 	 0.2
granules/m2 (n  20 cells) in BKO -cells and 1.6 	 0.2
granules/m2 (n  15 cells) in control -cells (P 
 0.001). To
determine whether BIG3 depletion affected the number of
docked granules and releasable pool granules, which are de-
fined according to their cellular localization (33, 39), we
quantified the number of granules according to their distance
from the plasma membrane. The distance of granules from
plasma membrane was defined as the minimum distance be-
tween granule membrane and plasma membrane (Fig. 5C,
inset). Granules directly touching plasma membrane without
any cytoplasma in between are generally considered to be
docked granules in endocrine cells such as chromaffin cells and
-cells (5, 33, 39, 48). Strikingly, although the total number of
granules was increased by 60% in BKO cells, we did not
detect any significant difference in the number of docked
granules between BKO (0.15 	 0.01 granules/m2) and con-
trol cells (0.14 	 0.03 granules/m2, P  0.05). We observed
a trend of more granules in the 
600-nm range in BKO than
control cells (Fig. 5C). Remarkably, the number of granules at
600 nm from plasma membrane was greatly increased in
BKO cells (Fig. 5C). These granules likely represent the
releasable pool of newly formed secretory granules, which is
consistent with the notion that BIG3 is a regulator of granule
biogenesis and is unlikely to be involved in granule docking or
fusion.
Increased granule biogenesis supports enhanced ATP re-
lease under prolonged stimulation in BKO -cells. According
to the definition of various pools of secretory granules, docked
and primed granules are released first during stimulation,
whereas the releasable pool is mobilized to support the sus-
tained phase of release (33, 39). Moreover, newly synthesized
insulin granules appear to be preferentially released compared
with aged granules (7, 11, 12, 17, 36, 42). Therefore, it is
conceivable that enhanced insulin granule production leads to
an increased pool of fresh insulin granule and in turn enhanced
granule exocytosis. To test this model, we plotted the ratio of
ATP release from BKO and control cells (ATPBKO/ATPCtrl)
against recording time. There was no difference in the number
of morphologically docked granules and granules close to the
plasma membrane between BKO and control cells (Fig. 5C).
Consistently, we did not observe any significant difference in
ATP release between BKO and control cells during early time
points of the recording (Fig. 6). The ratio of ATP release
increased steadily over time, whereas the P value (paired
Student’s t-test) rapidly decreased. At the 90-s time point and
onward, the ratio of ATP release (ATPBKO/ATPCtrl) reached
and surpassed 2 and became statistically significant. Taken
together, these results support the model that increased granule
exocytosis is the result of enhanced insulin granule biogenesis
and an increased releasable pool of newly formed insulin
granules.
DISCUSSION
Previously, we reported that BIG3 functions as a negative
regulator of insulin granule biogenesis in pancreatic -cells.
Here, we have established an electrophysiology method with
high temporal resolution to further show that depletion of BIG3
increases exocytosis frequency in -cells without affecting
quantal size or release kinetics of individual insulin granules.
BIG3 depletion has no effect on the number of docked granules
or granules located close to the plasma membrane but increases
the size of the releasable pool of newly formed insulin granules
deep in the cytosol of -cells, which accounts for the increased
insulin granule exocytosis and insulin secretion during pro-
longed stimulation.
Whole cell membrane capacitance measurement and amper-
ometry recording are two routine approaches in the detection of
vesicle exocytosis and quantal release, respectively. Whole cell
membrane capacitance measurement is widely used to study
vesicle fusion in endocrine cells, but it cannot resolve quantal
exocytosis (39). Amperometry can be used to study the kinetics
of single vesicle exocytosis in chromaffin cells and dopami-
nergic neurons (37, 47). However, for endocrine cells without
oxidizable transmitters, such as -cells, an oxidizable trans-
mitter (e.g., 5-HT) needs to be loaded into secretory granules
as a surrogate to report single-vesicle exocytosis in amperom-
etry recording (21, 50). Loading of oxidizable transmitters
could damage cells, possibly because of the generation of
reactive oxygen species (Liu T and Zhou Z, unpublished
observations). Compared with these two methods, the current
ATP-P2X2 assay directly detects endogenous ATP, which is
costored and coreleased with insulin, at sufficiently high tem-
poral resolution to resolve quantal release (21). Taken together,
the ATP-P2X2 assay is a very suitable method to study quantal
events and release kinetics of insulin granule exocytosis.
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The BIG/Sec7p Arf-GEF family members play significant
and general roles in various steps of the secretory pathway (8,
9). GBF1 acts primarily at the endoplasmic reticulum-Golgi
interface, whereas BIG1 and BIG2 function at the trans-Golgi
network (27, 40). Although BIG1, BIG2, and GBF1 are ex-
pressed ubiquitously, BIG3 is expressed mainly in the brain
and pancreatic islet (24), suggesting a specific function of
BIG3 in these tissues. In this study, we established the ATP-
P2X2 assay in -cells and recorded ATP currents to assess the
potential role of BIG3 in the regulation of exocytotic events
and its contribution to increased insulin secretion. ATP release
is greatly enhanced in BKO -cells, consistent with increased
insulin secretion in BKO -cells as measured by ELISA (24).
The increased release may be the result of increased quantal
size and/or release frequency. We found that BKO increased
granule exocytosis frequency in -cells but not quantal size.
The increased exocytosis frequency is further confirmed by
FM1-43 staining experiments. It is worth noting that BIG3
depletion did not alter exocytosis kinetics of insulin granules in
-cells, suggesting that BIG3 does not act on the fusion
machinery that is responsible for granule exocytosis and fur-
ther supporting BIG3 function in the secretory granule biogen-
esis process.
Although the total number of insulin granules was increased
by more than 60%, the number of morphologically docked
granules was not increased in BKO -cells. Docking of secre-
tory vesicles and granules at the plasma membrane is regulated
by an evolutionarily conserved protein complex consisting of
at least some the following core components: RIM, Munc13,
RIM-BP, -liprin, and ELKS proteins (45). It is plausible that
the docking machinery and sites may be limited (20), and thus
the total number of docked granules is limited regardless of the
number of total secretory granules. The fact that BIG3 deple-
tion has no effect on granule docking is consistent with the
model that BIG3 functions upstream of granules exocytosis in
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-cells. Further analysis showed that only the late-stage ATP
release was significantly increased in BKO -cells, consistent
with the electron microscopy result showing a similar number
of docked granules and increased releasable pool of newly
formed granules in BKO -cells.
Time scale and extent of release events appear to be depen-
dent on the methods of choice. In perifusion studies, insulin
secretion from isolated islets is usually measured over a period
of 30–60 min (14). In contrast, single-cell electrophysiology
measurements, such as whole cell membrane capacitance re-
cording and the ATP-P2X2 assay, show much higher exocy-
tosis frequency at earlier time points (21, 39, 44). As such,
130–180 s of intracellular Ca2 dialysis may be considered a
prolonged stimulation. Indeed, we observed most release
events in the first 130 s of stimulation in our experiments. In
perifusion studies of GSIS, glucose must enter -cells and
undergo metabolic changes and a series of membrane events to
result in elevated intracellular Ca2 levels, which should be
much slower compared with membrane depolarization-induced
Ca2 influx or intracellular dialysis of Ca2 using the patch
pipette (41). The temporal difference in raising intracellular
Ca2 levels may account for the difference in release fre-
quency at earlier time points measured by the two methods.
Our findings are consistent with previous studies using total
internal reflection fluorescence microscopy to analyze insulin
granules dynamics, which showed that most insulin granules
fuse directly with plasma membrane without docking (de-
scribed as restless newcomer) (10, 43). All these data indicate
that docked granules may contribute to a only minor compo-
nent of insulin secretion, and deep granules (reserved granules)
are the main source of insulin secretion from -cells.
In summary, our present study supports that BIG3 functions
as a negative regulator of granule biogenesis and rules out its
potential involvement or regulation of the exocytotic machin-
ery in -cells. Moreover, this study offers a mechanism in
understanding how increased granule biogenesis may lead to
increased frequency of secretory granule exocytosis and, con-
sequently, increased insulin secretion.
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